MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-18-2026
InspireMD Accounts Receivables 2011-2026 | NSPR
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables InspireMD
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.17 M | 1.57 M | 1.8 M | 1.03 M | 1.22 M | 476 K | 823 K | 716 K | 643 K | 356 K | 405 K | 635 K | 1.86 M | 1.82 M | 2.28 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.28 M | 356 K | 1.19 M |
Quarterly Accounts Receivables InspireMD
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.96 M | 1.59 M | 1.58 M | 1.57 M | 1.53 M | 1.31 M | 1.19 M | 1.8 M | 1.04 M | 1.47 M | 1.42 M | 1.03 M | 1.17 M | 1.18 M | 1.11 M | 1.22 M | 971 K | 962 K | 708 K | 476 K | 476 K | 476 K | 476 K | 823 K | 823 K | 823 K | 823 K | 716 K | 716 K | 716 K | 716 K | 643 K | 643 K | 643 K | 643 K | 356 K | 356 K | 356 K | 356 K | 405 K | 405 K | 405 K | 405 K | 635 K | 635 K | 635 K | 635 K | 1.86 M | 1.86 M | 1.86 M | 1.86 M | 1.27 M | 1.08 M | 1.82 M | 1.82 M | 2.28 M | 1.78 M | 614 K | 2.28 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.28 M | 356 K | 1.04 M |
Accounts Receivables of other stocks in the Medical devices industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apollo Endosurgery
APEN
|
15 M | - | - | $ 475 M |  USA |
 |
Aziyo Biologics
AZYO
|
1.73 M | - | 1.37 % | $ 20.5 M | USA |
 |
AdaptHealth Corp.
AHCO
|
371 M | $ 13.27 | -1.35 % | $ 1.79 B | USA |
 |
Allied Healthcare Products
AHPI
|
2.37 M | - | 3.58 % | $ 2.21 M | USA |
 |
Avinger
AVGR
|
1.01 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
5.48 M | - | -13.19 % | $ 166 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
44.8 M | - | - | $ 3.31 B | USA |
 |
BioSig Technologies
BSGM
|
109 K | - | 37.08 % | $ 85.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
18.6 M | $ 3.3 | -0.15 % | $ 124 M |  France |
 |
Conformis
CFMS
|
9.77 M | - | - | $ 16.4 M | USA |
 |
Electromed
ELMD
|
24.7 M | $ 25.74 | - | $ 218 M | USA |
 |
Cardiovascular Systems
CSII
|
39.7 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
7.55 M | $ 0.64 | 6.67 % | $ 39.8 M | USA |
 |
ClearPoint Neuro
CLPT
|
6.55 M | $ 10.74 | -3.07 % | $ 304 M | USA |
 |
Dynatronics Corporation
DYNT
|
2.8 M | - | 14.99 % | $ 929 K | USA |
 |
Globus Medical
GMED
|
679 M | $ 89.45 | -1.39 % | $ 12.1 B | USA |
 |
Eargo
EAR
|
1.91 M | - | - | $ 10.2 M | USA |
 |
Second Sight Medical Products
EYES
|
455 K | - | -0.97 % | $ 54.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
117 K | $ 2.07 | -0.48 % | $ 1.26 M | USA |
 |
GBS
GBS
|
595 K | - | -0.57 % | $ 7.12 M | USA |
 |
Butterfly Network
BFLY
|
20.8 M | $ 5.07 | -1.65 % | $ 1.07 B | USA |
 |
Pulmonx Corporation
LUNG
|
12.1 M | $ 1.23 | 0.41 % | $ 50 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
53.8 M | $ 14.87 | -1.78 % | $ 349 M | USA |
 |
Delcath Systems
DCTH
|
11.7 M | $ 10.31 | -2.27 % | $ 369 M | USA |
 |
Orthofix Medical
OFIX
|
136 M | $ 11.62 | -2.43 % | $ 460 M |  Curacao |
 |
IRIDEX Corporation
IRIX
|
7.61 M | $ 1.03 | -0.96 % | $ 17.4 M | USA |
 |
Insulet Corporation
PODD
|
161 M | $ 180.5 | -1.3 % | $ 12.7 B | USA |
 |
CONMED Corporation
CNMD
|
248 M | $ 36.61 | -0.49 % | $ 1.14 B | USA |
 |
LivaNova PLC
LIVN
|
216 M | $ 60.23 | -1.73 % | $ 3.29 B |  Britain |
 |
Inspire Medical Systems
INSP
|
120 M | $ 54.6 | -0.9 % | $ 1.6 B | USA |
 |
LENSAR
LNSR
|
6.38 M | $ 5.29 | -1.12 % | $ 63.3 M | USA |
 |
Integer Holdings Corporation
ITGR
|
346 M | $ 83.71 | -1.1 % | $ 2.91 B | USA |
 |
Invacare Corporation
IVC
|
88 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
660 M | $ 81.55 | -0.89 % | $ 47.7 B | USA |
 |
Sintx Technologies
SINT
|
178 K | $ 2.13 | -0.7 % | $ 5.91 M | USA |
 |
Stryker Corporation
SYK
|
4.04 B | $ 315.23 | -1.95 % | $ 120 B | USA |
 |
MiMedx Group
MDXG
|
75.7 M | $ 3.37 | -0.88 % | $ 498 M | USA |
 |
Tactile Systems Technology
TCMD
|
43.9 M | $ 22.99 | -2.46 % | $ 526 M | USA |
 |
TELA Bio
TELA
|
10.3 M | $ 0.77 | -1.28 % | $ 36.1 M | USA |